Featured Lecture: The Future of Interventional Therapies For Heart Failure

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Study honoraria to institution, travel expenses, consulting fees (Relationships with industry are limited to reimbursement for clinical trials. Personal honoraria had not been paid) (Institutional) - 4tech Cardio, Abbott, Ablative Solutions, Ancora Heart, Append Medical, Axon, Bavaria Medizin Technologie GmbH, Bioventrix, Boston Scientific, Carag, Cardiac Dimensions, Cardiac Success, Cardimed, Celonova, Contego, CVRx, Dinova, Edwards, Endomatic; Hemoteq, Hangzhou Nuomao Medtech, Holistick Medical, K2, Lifetech, Mokita, Occlutech, Recor, Renal Guard, Trisol, Vascular Dynamics, Vectorious Medtech, Venus, Venock, Vivasure Medical